Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Approves Anthrax Treatment

March 25, 2015 1:10 pm | by Stephanie Guzowski, Editor | News | Comments

The Food and Drug Administration (FDA) yesterday approved Emergent BioSolutions’ infusible drug Anthrasil for use in combination with antibiotics to treat inhalational anthrax, which happens when bacterial spores that carry anthrax are breathed in. Read more...

TOPICS:

Sepsis-Specific Treatment Market Will Expand from 2016, Reach $354M by 2021

March 25, 2015 12:28 pm | by Marc C. Hansel, Ph.D., GlobalData Infectious Diseases Analyst | Articles | Comments

GlobalData's latest report states that this growth will be driven by the increased uptake of novel therapies. Read more...

TOPICS:

Science, Patients Driving Rare Disease Drug Research Surge

March 25, 2015 11:34 am | by Linda A. Johnson, AP Business Writer | News | Comments

The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits. Read more...

TOPICS:
Advertisement

Antibiotics Pipeline Boasts 741 Products, but First-in-class Development Remains Low: GBI Research

March 25, 2015 9:48 am | News | Comments

While antibiotics boast a vast pipeline, with 741 products currently in development, the majority is dominated by generics, as weak financial incentives and high failure rates have discouraged innovation, says business intelligence provider GBI Research. Read more..

TOPICS:

Biocept Enters Clinical Collaboration With UC, San Diego Moores Cancer Center

March 25, 2015 9:42 am | News | Comments

Biocept, Inc., a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs), announced that it has entered into a clinical collaboration with University of California, San Diego Moores Cancer Center.

TOPICS:

Non-FDA Approved Hormone Therapies on the Rise

March 25, 2015 9:36 am | by Cynthia Fox, Science Writer | Articles | Comments

Use of potentially risky, non-FDA approved hormone therapies may soon be as common as use of FDA-approved hormone therapies, according to a study by University of Virginia gynecology researcher JoAnn Pinkerton. Read more..

TOPICS:

Blueprint Medicine Files for IPO

March 25, 2015 9:30 am | by Ryan Bushey, Associate Editor | Articles | Comments

The biotech firm is making a big bet on the success of its precision therapies. Read more...

TOPICS:

Takeda Licenses Rights to Use Immunogen's Technology to Develop Anticancer Therapies

March 25, 2015 8:44 am | News | Comments

Takeda will use the technology to develop and commercialize targeted anticancer therapeutics to up to two undisclosed  targets. Read more...

TOPICS:
Advertisement

GSK Seeks Early Drug Discovery Partnerships with Academics in Europe, Canada, and U.S.

March 25, 2015 8:37 am | News | Comments

This program designed to accelerate the translation of early-stage research into game-changing new medicines. Read more...

TOPICS:

Blood Test Could Help Bowel Cancer Patients Avoid Drug Side-Effects

March 25, 2015 8:33 am | by University of Manchester | News | Comments

Researchers have provided early evidence to suggest that a blood test could be used to identify bowel cancer patients that may benefit from more intensive chemotherapy. Read more...

TOPICS:

Researchers Identify Red Blood Cell Traits Associated with Malaria Risk in Children

March 25, 2015 8:27 am | by NIAID | News | Comments

The findings could help identify future targets for new malaria drugs and vaccines. Read more...

TOPICS:

Official: Ebola Survivor May Have Infected New Liberia Case

March 25, 2015 8:21 am | by Jonathan Paye-Layleh, Associated Press | News | Comments

A woman who tested positive for Ebola in Liberia last week is dating a survivor of the disease. Read more...

TOPICS:

Potential for ALS Treatment Found in Three Proteins

March 25, 2015 8:17 am | by David Callahan, KTH Royal Institute of Technology | News | Comments

Recent research at Sweden's KTH Royal Institute of Technology has found three proteins that could shed some light on the mechanisms behind ALS. Read more...

TOPICS:

Study of Thousands of Brains Reveals Tau as Driver of Alzheimer's

March 24, 2015 12:58 pm | by Mayo Clinic | News | Comments

By examining more than 3,600 postmortem brains, researchers at Mayo Clinic's campuses in Jacksonville, Florida, and Rochester, Minnesota, have found that the progression of dysfunctional tau protein drives the cognitive decline and memory loss seen in Alzheimer's disease. Read more...

TOPICS:

Nanotechnology Platform Shows Promise for Treating Pancreatic Cancer

March 24, 2015 12:48 pm | by UCLA | News | Comments

Scientists at UCLA’s California NanoSystems Institute and Jonsson Comprehensive Cancer Center have combined their nanotechnology expertise to create a new treatment that may solve some of the problems of using chemotherapy to treat pancreatic cancer. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading